HD-OPM Archive
Topics › Lp(a)

Lp(a) has no known essential role in modern humans and may even have minor upsides

Louis Nervegna · Sep 16, 2026 · ♥ 6 reactions · 2 comments · original Facebook post
Lp(a)
AI summary & key facts

Louis explains that people with very low or undetectable Lp(a) show no significant ill effects, so it does not appear essential today. It may have conferred an evolutionary advantage to hunter-gatherer ancestors, and high Lp(a) might lower the risk of some conditions such as diabetes and hemorrhagic stroke, even though it strongly raises CVD risk. He supports this with an AI-generated explanation.

Does Lp(a) play any essential role in the bloodstream?
The short answer is No.

Modern humans with little to no Lp(a) in their blood experience no significant side effects as a result.

However, it may have provided an evolutionary advantage to your ancient hunter-gatherer ancestors, which is why evolution seems to have selected for it in many people.

And high Lp(a) might actually lower the risk for developing certain diseases and conditions, like diabetes and hemorrhagic stroke. In other words, there might be some minor advantages to having high Lp(a), even though it strongly raises risk for CVD.

Here is a nice explanation from Gemeni AI:

Lipoprotein(a), commonly referred to as Lp(a), does not appear to have an essential physiological function in modern humans.

Individuals with extremely low or completely undetectable blood levels of Lp(a) suffer no obvious biological deficits, developmental issues, or functional impairment. Because of this, many lipidologists and evolutionary biologists view Lp(a) as an evolutionary remnant—a biological "fossil"—rather than a vital protein required for day-to-day metabolic health.

However, based on its molecular architecture (an LDL-like particle covalently bound to apolipoprotein(a), which shares high structural homology with plasminogen), several hypothesis-driven roles for Lp(a) have been proposed:

Proposed Evolutionary & Physiological Roles

The Modern Paradox

While these mechanisms likely offered a survival edge in hunter-gatherer eras characterized by frequent physical trauma and shorter lifespans, they become detrimental over a modern lifespan.

The exact traits that made Lp(a) useful for acute survival—pro-thrombotic properties (inhibiting clot breakdown) and pro-inflammatory activity (delivering oxidized lipids directly to vessel walls)—make it a potent driver of premature atherosclerotic plaque formation, aortic valve stenosis, and thrombosis today.

Could high Lp(a) protect against certain diseases and conditions?

Observational epidemiological data and Mendelian randomization studies show inverse associations between high Lp(a) levels and a few specific conditions. However, clinicians generally treat these "protective" effects as physiological trade-offs rather than actionable therapeutic benefits, because the cardiovascular harms of high Lp(a) almost always far outweigh the advantages.

The primary conditions where high Lp(a) appears to confer lower risk include:

  1. Type 2 Diabetes Mellitus

Large population studies (including data from the Copenhagen City Heart Study and UK Biobank) demonstrate a clear, inverse observational relationship between Lp(a) concentration and new-onset type 2 diabetes.

  1. Bleeding Complications & Hemorrhagic Stroke

Because apolipoprotein(a) shares high structural homology with plasminogen, it acts as a competitive inhibitor of fibrinolysis (the body’s process of breaking down blood clots).

  1. Infectious and Parasitic Disease Progression (Hypothesized/In Vitro)

Some specialized functional research suggests high Lp(a) may help bind and neutralize specific bacterial toxins and lipopolysaccharides (LPS).

Key Clinical Context

While having high Lp(a) offers a statistically lower risk profile for conditions like type 2 diabetes, it is not considered clinically protective overall.

Elevated Lp(a) remains a major, independent causal driver of atherosclerotic cardiovascular disease (ASCVD), coronary artery disease, calcific aortic valve stenosis, and ischemic stroke. In clinical practice, any potential metabolic or pro-hemostatic advantage provided by high Lp(a) is massively overshadowed by its cardiovascular risk profile.

#lpaHD #oxplHD #evolutionHD

← newer: How nitric oxide relaxes blood vessels and regulates blood folder: Harvard cohorts: plant protein linked to lower CVD and total →